All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 126–150 of 169 drugs · filtered

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · RENAL CELL CARCINOMA ·+3
NOVADOZ PHARMAC

HERNEXEOS (zongertinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2 POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER W/ TYROSINE KINASE DOMAIN ACTIVATING MUTATIONS
Boehringer Ingelheim

PHYRAGO (dasatinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
CYCLE PHARMACEU

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
BLUEPOINT/ONCOP

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
TEVA PHARM

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+11
CAMBER PHARMACE

NILOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
DR.REDDY'S LAB

NILOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
CAMBER PHARMACE

NILOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
NOVADOZ PHARMAC

HYRNUO (sevabertinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2 POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER W/ TYROSINE KINASE DOMAIN ACTIVATING MUTATIONS
Bayer HealthCare

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
LUPIN PHARMACEU

NILOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
TORRENT PHARMAC

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
AVKARE

GLEEVEC (imatinib mesylate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+11
Novartis Pharmaceuticals

RYDAPT (midostaurin)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ACUTE MYELOID LEUKEMIA WITH FMS-LIKE TYROSINE KINASE-3 (FLT3) MUTATION ·+3
Novartis Pharmaceuticals

SCEMBLIX (asciminib hydrochloride)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
Novartis Pharmaceuticals

TABRECTA (capmatinib hydrochloride)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING
Novartis Pharmaceuticals

TASIGNA (nilotinib HCl)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
Novartis Pharmaceuticals

TYKERB (lapatinib ditosylate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
Novartis Pharmaceuticals

VOTRIENT (pazopanib HCl)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SOFT OR CONNECTIVE TISSUE SARCOMA ·+1
Novartis Pharmaceuticals

ZYKADIA (ceritinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
Novartis Pharmaceuticals

NILOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
AVKARE

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
DR.REDDY'S LAB

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
APOTEX CORP